HeyGen is now HIPAA-eligible for Enterprise customers, with a Business Associate Agreement (BAA) that enables healthcare and life sciences organizations to securely create personalized AI videos involving protected health information.
In enterprise conversations across healthcare and life sciences, the bottleneck for AI adoption has never been a lack of vision. It has been trust, security, and compliance.
The question I hear constantly from commercial leaders and CMOs is straightforward:
“We see the transformative ROI of HeyGen, but can we deploy it across workflows involving patient data?”
Until now, enterprise governance required that answer to be no.
Today, that changes.
I’m thrilled to announce that HeyGen now supports HIPAA-eligible workflows for Enterprise customers, backed by a formal Business Associate Agreement (BAA).
This isn't just a regulatory checkbox for us, it is an enterprise unlock. It allows healthcare systems, pharmaceutical enterprises, and digital health platforms to transition AI video from top-of-funnel marketing directly into mission-critical, patient-specific operations.
Why This Matters: Scaling the Human Element in Care
Healthcare communication carries zero margin for error. Delivering personalized, highly technical clinical information across diverse patient populations and global markets has historically meant:
- Prohibitive production costs and months-long turnaround times.
- Friction in updating content as clinical guidelines or treatment protocols evolve.
- Significant gaps in health equity due to language barriers.
With HeyGen, healthcare organizations can now scale their most credible assets—their key opinion leaders (KOLs), clinicians, and care teams—into dynamic, localized video across 177+ languages and dialects.
With HIPAA-eligible infrastructure and a BAA in place, organizations can securely apply this capability to workflows involving Protected Health Information (PHI).
The Life Sciences Advantage: Credibility Meets Velocity
In pharmaceuticals and biotech, message delivery is as vital as the data itself.
When a physician or patient evaluates a therapy, trust is anchored in the authority of the speaker. HeyGen enables life sciences teams to preserve the authenticity and presence of trusted medical experts while decoupling production from traditional studio constraints.
When integrated with standard enterprise medical/legal/regulatory (MLR) review workflows, this fundamentally changes commercial and clinical velocity across key touchpoints:
- Hyper-Personalized Patient Education: Tailored treatment, procedure, and adherence guidance delivered in the patient’s preferred language.
- Discharge & Post-Care Engagement: Clear, humanized instructions that drive treatment adherence and mitigate readmission risks.
- Patient Support Programs (PSPs): Scalable, high-touch communication across the entire therapy lifecycle.
- Omnichannel HCP Engagement: Compliant, real-time medical updates delivered by recognized KOLs directly to practitioners.
- Global Clinical Trial Recruitment & Training: Consistent, culturally resonant trial onboarding at global scale.
Enterprise Trust: Security as Table Stakes
True enterprise AI must be built on uncompromising governance.
HeyGen executes BAAs with qualified Enterprise clients, establishing a clear shared-responsibility model to ensure PHI is handled in full accordance with HIPAA standards within designated services. Compliance and data sovereignty remain foundational to our enterprise product roadmap.
(Note: PHI should only be introduced under an executed BAA within designated HIPAA-eligible environments.)
What’s Ahead
For the commercial and clinical leaders who have been waiting to unlock personalized video at scale: the infrastructure is ready.
If your team is evaluating how generative video can elevate patient outcomes, compress clinical timelines, or scale your commercial footprint, our Enterprise Healthcare & Life Sciences team is ready to partner with you.
Let’s build the future of healthcare communication together.
